Khonsu Therapeutics

Novel biologic for inflammation in human and animal health

Company Details

Khonsu Therapeutics is developing a novel biologic to treat diseases as a result of inflammation in human and animal health. We will initially focus on developing a therapeutic for the equine market, treating lameness and arthritis in horses due to inflammation.

  • Pitch Video

Company People

Tom Moore

Tom Moore

Emer Shea

Emer Shea
CEO & Co-Founder

Khonsu Therapeutics News


You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision.  Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.